4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-008890
General Counsel sold 3,576 shares at $29.84 ($106,701)
- General Counsel acquired 16,644 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wilson Martin · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-16 | Sale : show line 1 in the form | −3,576 | $29.84 | $106,701 | 6,136 | D |
| 2024-02-16 | Grant or award : show line 2 in the form | +16,644 | 22,780 | D | ||
| Open-market sales · 3,576 sh · avg $29.84 · $106,701 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-16 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +49,091 | 49,091 | D |
Loading xslF345X05/form4.xml…